What is it about?
Guanfacine XR is a novel non-stimulant medication for treating children and adolescents with ADHD, with a distinct mechanism of action. It has the particularity that is has not only proven to be useful a treatment on its own, but also as an add-on pharmacotherapy to stimulants and has been shown to be efficacious as well for patients with ADHD and comorbid conduct disorder.
Featured Image
Why is it important?
It is an updated, thorough and critical review on the efficacy and tolerability of the alpha-2a-agonist
Perspectives
The publication ought to be very useful for academics, clinicians and researchers as it provides a comprehensive and up-to-date of this novel pharmacological option.
Dr Jose Martinez-Raga
Hospital Universitario Dr. Peset & University of Valencia
Read the Original
This page is a summary of: Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder, May 2015, Dove Medical Press, DOI: 10.2147/ndt.s65735.
You can read the full text:
Contributors
The following have contributed to this page
